Fighting to Preserve the Benefits of the 340B Program
VP of Pharmacy for Positive Impact Health Centers Emily Blaiklock on 340B Generic Drug Program for Rural/Ryan White Clinics WOYM 10-4, listen to the interview here: https://wlds.com/audio/vp-of-pharmacy-for-positive-impact-health-centers-emily-blaiklock-on-340b-generic-drug-program-for-rural-ryan-white-clinics-woym-10-4/
On October 2, 2024, CMS published final guidance on the implementation of the Medicare Part D price caps for the 2026 and 2027 calendar years under the Inflation Reduction Act…
Effective September 30, 2024, CMS finalized its National Coverage Determination (NCD) for PrEP, which moves coverage for PrEP from Medicare Part D to Part B and requires reimbursement for certain…
Yesterday, Johnson & Johnson Health Care System Inc. (J&J) stated in a letter to HRSA that it will halt implementation of its proposed rebate model, which was set to take…
Today, the Health Resources and Services Administration (HRSA) issued a letter to Johnson and Johnson Health Care System Inc. (J&J) calling for the manufacturer to “cease implementation of its rebate…
Beginning October 1, 2024, AstraZeneca will require all covered entities to submit 340B claims utilization data to ESP™ as a pre-requisite for designating a single contract pharmacy. This announcement, released…
EMD Serono (EMDS) announced that it will apply its contract pharmacy restrictions to all covered entities beginning October 1, 2024. EMDS is allowing an exception to Ryan White Clinics for purchases…
Johnson & Johnson Health Care System Inc. (J&J) announced last week that, effective October 15, 2024, disproportionate share hospital (DSH) covered entities will no longer have access to up-front 340B…
CMS announced that it expects to release a final National Coverage Determination (NCD) late next month that will move the PrEP coverage benefit from Medicare Part D to Medicare Part…
On June 21, 2024, the American Journal of Managed Care ran an article titled “Protecting the 340B Program Vital for Providing the Best Care to Patients With HIV” that detailed…